| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |